Jessica Mintz
jmintz.bsky.social
Jessica Mintz
@jmintz.bsky.social
Vascular medicine specialist at Lahey hospital.
Medical Director for outpatient anticoagulation services, Beth Israel Lahey Health.
Mom of 4.
Reposted by Jessica Mintz
For patients with IgG4-related disease, there are no approved therapies. Research findings on the efficacy and safety of inebilizumab ― a monoclonal antibody that targets and depletes CD19+ B-cells ― are summarized in a new Quick Take video. nej.md/421enZX

#MedSky #RheumSky
Inebilizumab for IgG4-Related Disease | NEJM
Quick Take Video Summary from The New England Journal of Medicine — Inebilizumab for IgG4-Related Disease
nej.md
March 30, 2025 at 1:09 PM
Reposted by Jessica Mintz
We are excited to announce a new advanced endovascular interventional program starting this July 2025. It is a unique program with shared training between Interventional cardiology and vascular surgery! Contact me at
michael.s.levy@lahey.org to learn more!
November 25, 2024 at 7:31 PM
Reposted by Jessica Mintz
🌟Come Join Our Team🌟
🌟2 New Positions, remote/hyrbid🌟
We are looking for skilled Anticoag Pharmacists to grow our Stewardship program. This role will focus on CDTM based outpt mgmt of antithrombotic therapy
#AnticoagStewardship #jobs #pharmacist

jobs.bilh.org/job/burlingt...
Clinical Pharmacist Specialist Anticoagulation Hybrid / Remote at Beth Israel Lahey Health
Learn more about applying for Clinical Pharmacist Specialist Anticoagulation Hybrid / Remote at Beth Israel Lahey Health.
jobs.bilh.org
November 14, 2024 at 12:48 AM